New Haven Pharmaceuticals, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
New Haven Pharmaceuticals, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2014).
SEC Form D · Oct 2014
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Oct 2014
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of New Haven Pharmaceuticals, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Harry Penner, Jr. | Executive officer | Oct 2014 |
| Nancy Motola | Executive officer | Oct 2014 |
| Patrick Fourteau | Executive officer | Oct 2014 |
| Daniel Wagner | Director | Oct 2014 |
| Harry Penner, Jr. | Director | Oct 2014 |
| Larry Dillaha | Director | Oct 2014 |
| Patrick Fourteau | Director | Oct 2014 |
| William Sessa | Director | Oct 2014 |
| Harry Penner, Jr. | """Promoter"" is selected as this related person is a founder of the issuer." | Oct 2012 |
| Patrick Fourteau | """Promoter"" is selected as this related person is a founder of the issuer." | Oct 2012 |
| Rob Sterling | """Promoter"" is selected as this related person is a founder of the issuer" | Oct 2012 |
| Scott Kozak | """Promoter"" is selected as this related person is a founder of the issuer." | Oct 2012 |